Cargando…
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague–Dawley Rats †
Dietary and lifestyle changes are leading to an increased occurrence of non-alcoholic fatty liver disease (NAFLD). Using a hyperlipidemic murine model for non-alcoholic steatohepatitis (NASH), we have previously demonstrated that the lysosomal protease cathepsin D (CTSD) is involved with lipid dysre...
Autores principales: | Khurana, Princy, Yadati, Tulasi, Goyal, Sandeep, Dolas, Atul, Houben, Tom, Oligschlaeger, Yvonne, Agarwal, Anil K., Kulkarni, Aditya, Shiri-Sverdlov, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571693/ https://www.ncbi.nlm.nih.gov/pubmed/31060228 http://dx.doi.org/10.3390/biom9050171 |
Ejemplares similares
-
Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice
por: Yadati, Tulasi, et al.
Publicado: (2021) -
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
por: Yadati, Tulasi, et al.
Publicado: (2020) -
Inflammatory Bowel Disease: A Stressed “Gut/Feeling”
por: Oligschlaeger, Yvonne, et al.
Publicado: (2019) -
Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
por: Ding, Lingling, et al.
Publicado: (2019) -
Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals
por: Ding, Lingling, et al.
Publicado: (2020)